Featured Research

from universities, journals, and other organizations

Alzheimer's drug boosts perceptual learning in healthy adults

Date:
September 18, 2010
Source:
University of California - Berkeley
Summary:
Scientists have found that healthy adults showed greater improvement from practice on a motion direction discrimination task when they took donepezil, a commonly prescribed Alzheimer's drug, compared with when they took a placebo. The research is helping neuroscientists better understand perceptual learning in healthy adults.

Research on a drug commonly prescribed to Alzheimer's disease patients is helping neuroscientists at the University of California, Berkeley, better understand perceptual learning in healthy adults.

In a new study, to be published online Sept. 16 in the journal Current Biology, researchers from UC Berkeley's Helen Wills Neuroscience Institute and School of Optometry found that study participants showed significantly greater benefits from practice on a task that involved discriminating directions of motion after they took donepezil, sold under the brand name Aricept, compared with a placebo.

Neither the researchers nor the participants knew whether they were taking the placebo or donepezil, a cholinesterase inhibitor that enhances the effects of the neurotransmitter acetylcholine in the brain. Cholinesterase inhibitors act by blocking an enzyme that breaks down acetylcholine. Acetylcholine is known to play an important role in mediating visual attention and, in animal studies, has been found to promote changes in the brain that are associated with learning.

Donepezil, like other cholinesterase inhibitors, is used to treat early stages of Alzheimer's disease and dementia. Previous research on donepezil has focused primarily on its beneficial effects on quality of life and clinical symptoms in patient populations. However, little was known about the specific cognitive processes that are enhanced by this drug.

"We wanted to better understand the biological mechanisms that underlie the ability to learn new tasks and to shed light on which specific neural processes are being enhanced by donepezil," said the study's principal investigator, Michael Silver, UC Berkeley assistant professor of optometry and neuroscience. "This is the first study to show that donepezil can enhance learning of a new skill, even in normal, healthy people."

The researchers tested 12 healthy, non-smoking adults ages 18-35. Subjects were tasked with detecting whether or not two fields of moving dots, presented one after the other, were moving in the same direction.

Each subject completed two 5-day courses of training on this task. In one of these courses of training, subjects ingested 5 milligrams of donepezil before every training session, and in the other, they took a placebo capsule before each training session. On average, the amount of improvement in performance of the task due to training increased two-fold when training occurred under the influence of donepezil.

However, the study authors noted that the improvements in the task being learned did not result in the same amount of improvement in performance on new motion direction discrimination tasks.

"The effects of donepezil were very specific to the task that the subjects were learning and practicing, and improvements elsewhere were much more moderate," said study lead author Ariel Rokem, a UC Berkeley post-doctoral fellow at the Helen Wills Neuroscience Institute. "As a comparison, with practice, a fruit inspector may become very good at judging small differences in color among red apples, but this learning may not completely transfer to the ability to discriminate shades of green apples."

It would be helpful to test the effectiveness of donepezil on other forms of learning, the study authors said. "We've established that donepezil enhances learning, so now we want to understand how this happens in the brain," said Silver. "We have a study underway where we use brain imaging to measure how the brain changes with learning and the impact of donepezil on these neural changes."

The researchers said that if enhancing the activity of acetylcholine in the brain is shown to benefit other forms of perceptual learning, it could eventually lead to clinical treatments for people with conditions other than Alzheimer's.

"Perceptual learning tasks are used to help patients with clinical conditions such as dyslexia and amblyopia," said Rokem. "Further research could find that cholinesterase inhibitors boost the effectiveness of perceptual learning treatments for these patients."

The National Institutes of Health and the Hellman Family Faculty Fund helped support this research.


Story Source:

The above story is based on materials provided by University of California - Berkeley. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ariel Rokem, and Michael A. Silver. Cholinergic Enhancement Augments Magnitude and Specificity of Visual Perceptual Learning in Healthy Humans. Current Biology, 2010; DOI: 10.1016/j.cub.2010.08.027

Cite This Page:

University of California - Berkeley. "Alzheimer's drug boosts perceptual learning in healthy adults." ScienceDaily. ScienceDaily, 18 September 2010. <www.sciencedaily.com/releases/2010/09/100916121326.htm>.
University of California - Berkeley. (2010, September 18). Alzheimer's drug boosts perceptual learning in healthy adults. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2010/09/100916121326.htm
University of California - Berkeley. "Alzheimer's drug boosts perceptual learning in healthy adults." ScienceDaily. www.sciencedaily.com/releases/2010/09/100916121326.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins